About this trial
This study is for adults with COPD. Flare-ups of COPD, also known as exacerbations, can be serious and lead to hospital stays. The purpose of this research is to see if continuously and automatically monitoring a person's coughs can help predict these flare-ups early, before they become severe. Participants will use the Hyfe cough monitoring system, which includes a watch-like device worn on the wrist and a smartphone application. The system privately counts the number of coughs without recording any audio. Participants will also answer a short, weekly questionnaire about their COPD symptoms. This is an observational study, which means it will not change the regular medical care a participant receives. The participants and their care providers will not see the cough counts. The doctor will continue to manage their COPD as usual.
Eligibility criteria
Qualifiers
Must be 18 years of age or older.
Must have an existing diagnosis of COPD.
For the inpatient cohort, participants must be currently assessed as having a moderate/severe exacerbation.
For the outpatient cohort, participants must have had at least one exacerbation of any severity in the last 12 months.
Disqualifiers
Individuals who are unable to provide informed consent.
Individuals who are unable to adhere to study procedures.
For the inpatient cohort, individuals requiring invasive or non-invasive ventilation.
Individuals who live with a person who has a chronic cough.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Clinica Universidad de Navarra, Universidad de Navarra
Lead sponsor
Hyfe Inc
Collaborator